about
Heparin: Past, Present, and FutureMolecular cloning and expression of mouse and human cDNAs encoding heparan sulfate D-glucosaminyl 3-O-sulfotransferasePurification of heparan sulfate D-glucosaminyl 3-O-sulfotransferaseSynthesis of thrombin-inhibiting heparin mimetics without side effects.Parenteral anticoagulants: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice GuidelinesChemoenzymatic synthesis of heparin oligosaccharides with both anti-factor Xa and anti-factor IIa activities.Clinical efficacy of heparin fractions: issues and answers.A peptide found by phage display discriminates a specific structure of a trisaccharide in heparin.Cell mutants defective in synthesizing a heparan sulfate proteoglycan with regions of defined monosaccharide sequence.Factor X inhibitors.Anticoagulant heparan sulfate: structural specificity and biosynthesis.Structural determinants of the capacity of heparin to inhibit the proliferation of vascular smooth muscle cells. II. Evidence for a pentasaccharide sequence that contains a 3-O-sulfate group.Evaluation of critical groups required for the binding of heparin to antithrombin.Circular dichroism spectroscopy of heparin-antithrombin interactionsHeparin-catalyzed inhibitor/protease reactions: kinetic evidence for a common mechanism of action of heparin.Low molecular weight protamine (LMWP) as nontoxic heparin/low molecular weight heparin antidote (II): in vitro evaluation of efficacy and toxicity.Carbohydrate post-glycosylational modifications.New approaches for defining the molecular basis of anticoagulantly active heparan sulfate production.Interaction of heparin with fibronectin and isolated fibronectin domains.Effect of a pentosan polysulphate upon thrombin and factor Xa inactivation by antithrombin III.Anticoagulant activities of heparin oligosaccharides and their neutralization by platelet factor 4Binding of platelet factor 4 to heparin oligosaccharides.Structure and biological activity of finback-whale (Balaenoptera physalus L.) heparin octasaccharide. Chemical, carbon-13 nuclear-magnetic-resonance, enzymic and biological studies.Role of endothelial cell surface heparin-like polysaccharides.Antithrombogenic heparin-bound polyurethanes.Natural anticoagulant mechanisms.Glycosaminoglycans and the regulation of blood coagulation.Properties of antithrombin-thrombin complex formed in the presence and in the absence of heparinBiological implications of the structural, antithrombin affinity and anticoagulant activity relationships among vertebrate heparins and heparan sulphates.Changes in disaccharide composition of heparan sulphate fractions with increasing degrees of sulphation.Structure of heparin-derived tetrasaccharides.Mechanism of inactivation of trypsin by antithrombin.Structure-activity relationships of heparin. Independence of heparin charge density and antithrombin-binding domains in thrombin inhibition by antithrombin and heparin cofactor II.The relative molecular mass dependence of the anti-factor Xa properties of heparin.Structural glycobiology of heparin dynamics on the exosite 2 of coagulation cascade proteases: Implications for glycosaminoglycans antithrombotic activity.NIR-Emissive Alkynylplatinum(II) Terpyridyl Complex as a Turn-On Selective Probe for Heparin Quantification by Induced Helical Self-Assembly Behaviour
P2860
Q26744227-2FA8E781-ADB3-4BCE-87C8-CC2BA9847AB0Q28114813-D19AFA68-8A95-4E5F-B573-FDC73F75F8C3Q28295437-2F3CEF60-6C53-40FE-AA52-56093744AA43Q30573078-02FB43FC-3EFA-4E08-AB28-84AD7A2BD6B7Q33399576-CFFA1D53-3CEF-4625-984C-A95BD1CC5BE6Q33402197-77F19CB0-2F27-46EA-B6D7-AE5FED178887Q33411302-6A16D579-F504-4F37-8E41-9EE8D2B44089Q33824892-FEBCBF94-1D95-4C60-A8E7-10DB47D8E247Q33926104-0CD8776B-2E0E-4E28-A5E6-D3572ED9AE6BQ35117073-11FCC893-B184-4FCE-A9C2-9CAFDC83D31BQ35809426-91981513-ACB5-4183-BD29-A22F9ADA655CQ36214990-F5EE672D-9365-4495-9670-2D21D092E37AQ36248809-4C1A47FD-ABC2-4AA2-B05E-C69333762E54Q36322607-6B410232-CE6B-489E-B294-6D0B305AB994Q37348302-D8D64A02-3EFB-4AA0-9D49-1E480FD5360CQ37361505-4A6B9E37-9697-4296-9E49-4E7AAACC1A2DQ37403276-DACE41DC-A066-4F45-B455-7DD8396E9FDAQ38337186-CCCA0420-9460-42A7-B50B-AD91643094F7Q38337761-4359D434-2183-4607-8BBD-5FD6CC51FC11Q38353478-93043B92-FCF2-4087-A50D-321B4CA23F0EQ38353921-B629A4DC-C33B-409B-97EF-E8A8F26CA55CQ38354910-D5F09136-ECFB-4923-8218-6C106BABE984Q38355332-74B66621-9A0F-4C90-BD73-A5736C9F6E65Q38647598-92F0D56E-51CA-4FE1-917A-DF9A82986AEDQ39704582-456FDE6F-A0B6-48EE-B5D4-84C7C22D3698Q40143046-399A7F88-7A51-44FF-A429-A1A78740C432Q40851193-17DCE9A8-D2C0-455B-A02E-30F53468ECFDQ42063594-796C9B79-64DF-498D-85A3-38556369081BQ42165347-8D50AAC5-A47A-415B-BC4F-FFF13696C87AQ42285161-B6E88884-5204-4990-99BD-42C765DD9433Q42670467-757892D6-3055-4286-942C-25573A775C64Q42673196-D0BFE635-EC0B-4816-AFEB-59E47D994561Q42789989-2AF05443-468B-43AF-AF1E-5176D81B12B5Q42854432-F3E06031-7F1E-4629-9D8B-411BD98C8AC1Q44505808-3BF07156-D8DB-4E3F-BEB4-190184C8486CQ58864932-DC4AB94D-A32E-49B8-BE70-404C6893FE61
P2860
description
1981 nî lūn-bûn
@nan
1981 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
1981 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
1981年の論文
@ja
1981年論文
@yue
1981年論文
@zh-hant
1981年論文
@zh-hk
1981年論文
@zh-mo
1981年論文
@zh-tw
1981年论文
@wuu
name
Multiple functional domains of the heparin molecule
@ast
Multiple functional domains of the heparin molecule
@en
type
label
Multiple functional domains of the heparin molecule
@ast
Multiple functional domains of the heparin molecule
@en
prefLabel
Multiple functional domains of the heparin molecule
@ast
Multiple functional domains of the heparin molecule
@en
P2093
P2860
P356
P1476
Multiple functional domains of the heparin molecule
@en
P2093
D L Beeler
R D Rosenberg
W T Gardner
P2860
P304
P356
10.1073/PNAS.78.2.829
P407
P577
1981-02-01T00:00:00Z